As we know, TCM exerts therapeutic effects through multi-target and multi-pathway, the regulation of SGD on hormones disorder may be through hypothalamus–pituitary–gonadal axis or the enzymatic activity of ovarian P450arom and P450c17a or expression level of nuclear receptors. This evidence concerns the gene CYP19A1 and specific granule deficiency.